
Melanoma, the most aggressive skin cancer, poses a significant threat, even with recent advancements in immunotherapy. Late-stage diagnosis often leads to poor prognosis due to metastasis and drug resistance. Identifying new therapeutic targets is crucial. A study highlighted the anti-proliferative effects of alpha-2-macroglobulin (A2MG) from hibernating fish plasma, a potent protease inhibitor. Bioinformatics analysis across various cancer types, including melanoma, revealed significantly reduced A2MG expression. Higher A2MG expression correlated with improved overall survival, suggesting A2MG as a promising molecular target in melanoma and other cancers.
Like
Save
Share